Harnovi kills hepatitis C only in 8 weeks
Gilead Sciences’ hepatitis C treatment Harvoni(generic name: ledipasvir/sofosbuvir) have shown excellent efficacy only with a 8-week therapy, not 12 weeks.
Gilead Sciences Korea held a press conference to celebrate expanded health insurance benefits for Harvoni at The Westin Chosun Seoul on the ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.